Update 5:40 p.m. Both Bloomberg and The Wall Street Journal are reporting federal prosecutors and the Securities and Exchange Commission are investigating Theranos. Bloomberg identified the U.S. Attorney’s Office for the Northern District of California as launching a probe, and said Theranos had confirmed both investigations.
The Journal, citing anonymous sources, said that Walgreens and the New York State Dept. of Health have received subpoenas seeking information on Theranos' description of its technology.
Meanwhile, the SEC is looking into potentially deceptive statements Theranos may have made to investors, the paper said.